Microbia is an industrial biotechnology company focused on the development, production, and commercialization of specialty ingredients and biomaterials through fermentation technology. Its product portfolio includes carotenoids, specialty ingredients, biopolymers, and other biomaterials. The company targets markets that benefit from renewable and sustainable ingredients. Microbia has formed a strategic alliance with Tate & Lyle Investments, Ltd. to advance the development and commercialization of fermentation-derived renewable ingredients.
Microbia has made significant strides in the biotechnology sector by leveraging its expertise in fermentation technology to produce high-value specialty ingredients and biomaterials. The partnership with Tate & Lyle Investments has bolstered its capabilities in bringing innovative, sustainable products to market. This collaboration underscores Microbia's impact on the industry by promoting environmentally friendly alternatives and advancing the use of renewable resources in various applications.
